In several previous studies, TERTp mutations were not significantly associated with prognosis when adjusting for age and IDH mutations in GBM diagnosed according to the 2016 criteria [13,15,37], but in other studies, TERTp mutations were associated with the prognosis of GBM patients [18,36,48]. This evidence concerns the gene IDH2 and glioblastoma.